Guidance on the use of imatinib for chronic myeloid leukaemia

  • Technology appraisal guidance
  • TA70
  • Published: 
  • Last updated: 

Leukaemia (chronic myeloid) - imatinib: review decision

NICE Technology Appraisal Guidance No 70: on the use of imatinib for chronic myeloid leukaemia

Following consultation, the majority of comments received have led to the decision to defer the review of the existing guidance on the use of imatinib for chronic myeloid leukaemia until early 2009, pending the results of on-going trials due to complete in December 2007 and December 2008.

4 December 2006

This page was last updated: 30 March 2010